全文获取类型
收费全文 | 164430篇 |
免费 | 48861篇 |
国内免费 | 6551篇 |
专业分类
耳鼻咽喉 | 2218篇 |
儿科学 | 5087篇 |
妇产科学 | 1205篇 |
基础医学 | 23797篇 |
口腔科学 | 7041篇 |
临床医学 | 23768篇 |
内科学 | 33344篇 |
皮肤病学 | 8367篇 |
神经病学 | 16754篇 |
特种医学 | 5961篇 |
外国民族医学 | 41篇 |
外科学 | 23133篇 |
综合类 | 19049篇 |
现状与发展 | 18篇 |
一般理论 | 31篇 |
预防医学 | 11001篇 |
眼科学 | 3481篇 |
药学 | 15164篇 |
86篇 | |
中国医学 | 7079篇 |
肿瘤学 | 13217篇 |
出版年
2024年 | 344篇 |
2023年 | 1335篇 |
2022年 | 3334篇 |
2021年 | 5573篇 |
2020年 | 8429篇 |
2019年 | 13326篇 |
2018年 | 12705篇 |
2017年 | 14089篇 |
2016年 | 14331篇 |
2015年 | 15857篇 |
2014年 | 16861篇 |
2013年 | 17191篇 |
2012年 | 11358篇 |
2011年 | 11917篇 |
2010年 | 14740篇 |
2009年 | 10327篇 |
2008年 | 7548篇 |
2007年 | 6080篇 |
2006年 | 6075篇 |
2005年 | 5448篇 |
2004年 | 3874篇 |
2003年 | 3536篇 |
2002年 | 3192篇 |
2001年 | 2649篇 |
2000年 | 2282篇 |
1999年 | 1672篇 |
1998年 | 927篇 |
1997年 | 924篇 |
1996年 | 684篇 |
1995年 | 581篇 |
1994年 | 528篇 |
1993年 | 334篇 |
1992年 | 341篇 |
1991年 | 314篇 |
1990年 | 248篇 |
1989年 | 204篇 |
1988年 | 186篇 |
1987年 | 145篇 |
1986年 | 133篇 |
1985年 | 78篇 |
1984年 | 36篇 |
1983年 | 28篇 |
1982年 | 16篇 |
1981年 | 24篇 |
1980年 | 11篇 |
1979年 | 13篇 |
1978年 | 2篇 |
1973年 | 4篇 |
1972年 | 3篇 |
1966年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Very preterm children are at increased risk of reduced processing speed at 5 years of age,predicted by typical complications of prematurity and prenatal smoking 下载免费PDF全文
4.
5.
6.
目的探讨补骨脂素抗增生性瘢痕的作用机制。方法体外培养成纤维细胞,按随机数字表法分为正常组(培养正常成纤维细胞)、瘢痕组(培养增生性瘢痕成纤维细胞)、TGF-β1组(10 ng/ml TGF-β1处理增生性瘢痕成纤维细胞5 min^12 h)、Smurf2 RNA干扰组[Smad泛素化调节因子2(Smad ubiquitin regulatory factor2,Smurf2)siRNA转染增生性瘢痕成纤维细胞72 h]、补骨脂素组(10μmol/L补骨脂素处理增生性瘢痕成纤维细胞继续培养72 h)、补骨脂素+TGF-β1组(增生性瘢痕成纤维细胞加入补骨脂素培养72 h后加入TGF-β1培养6 h)。采用Western blot法检测Smurf2、α-平滑肌肌动蛋白(α-actin SMA,α-SMA)蛋白表达;RT-PCR法检测Ⅰ型胶原蛋白mRNA表达;ELISA法检测TGF-β1蛋白分泌。结果与正常组比较,瘢痕组Smurf2蛋白[(0.83±0.08)比(0.38±0.07)]表达增加(P<0.05);与瘢痕组比较,Smurf2 RNA干扰组TGF-β1[(2.2±0.18)比(4.2±0.47)]表达降低(P<0.05);TGF-β1组Smurf2[(0.71±0.06)比(0.42±0.04)]、α-SMA[(1.42±0.12)比(0.91±0.09)]蛋白表达增加(P<0.05),Ⅰ型胶原蛋白mRNA[(0.72±0.09)比(0.41±0.07)]表达增加(P<0.05);补骨脂素组Smurf2[(0.05±0.01)比(0.42±0.04)]、α-SMA[(0.71±0.07)比(0.91±0.09)]蛋白表达降低(P<0.05),Ⅰ型胶原蛋白mRNA表达[(0.12±0.04)比(0.41±0.07)]降低(P<0.05)。结论补骨脂素可能通过TGF-β1/Smurf2信号通路抑制α-SMA蛋白表达,从而降低Ⅰ型胶原蛋白表达,起到抑制瘢痕形成的作用。 相似文献
7.
Laparoscopic surgery has several advantages over traditional surgery because it has been shown to be less invasive. The next logical step in the evolution of minimally invasive surgery may be to eliminate all abdominal incisions. The natural orifices provide a port of entry via the gastrointestinal tract to the peritoneal cavity. This approach would require the creation of a perforation, which is considered to be a major complication of endoscopy with significant morbidity and mortality. However, there are several recent studies that have described the technical feasibility and safety of a per‐oral transgastric approach to the peritoneal cavity using conventional endoscopes. Theoretically, this approach could reduce postoperative abdominal wall pain, wound infection, hernia formation, and adhesions. This article aims to summarize the current status of transgastric surgery, currently referred to as natural orifice transluminal endoscopic surgery (NOTES), and to address some of its future challenges. 相似文献
8.
N. SUVAJD
I V. EMERIKI‐MARTINOVI . ARANOVI M. PETROVI M. POPOVI V. ARTIKO M. UPI I. ELEZOVI 《International journal of laboratory hematology》2006,28(5):317-320
We report the case of a littoral‐cell angioma of the spleen, a recently described benign vascular tumour, whose imaging and pathological characteristics have been discussed only by a few authors. The diagnosis was made after elective splenectomy. The CT images, scintigraphy and histological specimens are presented, and differential diagnoses discussed. 相似文献
9.
10.
Daoyan Wei Henry Q. Xiong James L. Abbruzzese Keping Xie 《Journal of gastrointestinal cancer》2003,33(1):43-60
Pancreatic cancer is a lethal disease characterized by early metastasis, local invasion, and resistance to conventional therapies. To understand its etiology and eventually make prevention of it possible and effective, appropriate carcinogenesis models will certainly help us understand the effects of environmental and genetic elements on pancreatic carcinogenesis. The development of new treatment strategies to control cancer metastasis is of immediate urgency. Fulfillment of this task relies on our knowledge of the cellular and molecular biology of pancreatic cancer metastasis and the availability of biologically and clinically relevant model systems. Many of the existing pancreatic cancer carcinogenesis and metastasis animal models are described in this review. The advantages and disadvantages of each model and their clinical implications are discussed, and special attention is focused on experimental therapeutic strategies targeting pancreatic cancer metastasis. 相似文献